The article highlights the observance of Rare Disease Day on February 29th, a date chosen for its rarity, and notes that in non-leap years, it is celebrated on February 28th. Initiated and coordinated by EURORDIS (European Organization for Rare Diseases) along with 65 partners across Europe, this day serves to raise awareness and promote advocacy for those affected by rare diseases at local, national, and international levels.

Experts point out that the post-COVID-19 era has transformed the landscape of clinical research and healthcare access for individuals suffering from rare diseases and their families. While most genetic disorders are classified as rare, the article clarifies that not all rare diseases are genetically based; some are extremely rare forms of infectious diseases, autoimmune conditions, and uncommon cardiovascular issues. This distinction sheds light on the broad spectrum of rare diseases, emphasizing the need for targeted strategies to address diverse health concerns.

The challenges of accessing timely treatments underscore the critical need for improved healthcare infrastructure, funding for research, and supportive policies that consider the unique needs of rare disease patients. The article calls for increased efforts in advocacy and awareness, highlighting ongoing issues that require immediate attention to facilitate better treatment options and healthcare services for those affected in Greece.